Donald Gainsborough is a seasoned political strategist and a leading voice at the intersection of public health and national legislation. As the architect behind Government Curated, he has become a central figure in navigating the complex alliance between the traditional Republican base and the rising “Make America Healthy Again” (MAHA) movement. His expertise is currently focused on how this populist health agenda will reshape the 2026 midterms and the future of federal health agencies.
How will the $100 million commitment be distributed across key districts to elect candidates who support the health agenda, and what specific metrics will be used to ensure they truly align with your goals?
The $100 million commitment from the MAHA PAC is a massive investment designed to move our agenda from the fringes of political discourse directly into the halls of Congress. We are identifying key battleground districts where voters are feeling the direct impact of the chronic disease crisis and the rising costs of healthcare. To ensure candidates are truly aligned, we aren’t just looking for lip service; we are measuring their willingness to challenge the existing agricultural subsidies and their public commitment to dismantling the corporate influence over our food supply. This funding will provide the necessary oxygen for a new breed of Republican who views national health as a primary pillar of national security.
Recent executive actions have prioritized boosting glyphosate production to assist farmers, despite advocacy for a total ban. How do you balance the immediate economic needs of the agricultural sector with long-term chemical concerns?
The recent executive order to increase glyphosate production has certainly created some friction, as a total ban remains a North Star for many in our movement. However, we are operating in lockstep with leadership to ensure that our transition to a cleaner food system doesn’t pull the rug out from under American farmers who are already struggling. We’ve held intense meetings with influential advocates like the “Glyphosate Girl” and wellness podcasters to bridge this gap and find a middle ground. The trade-off involves securing short-term agricultural stability while simultaneously building the infrastructure for a chemical-free future, ensuring that we don’t make life harder for the very people who feed the nation.
The current nominee for Surgeon General faces a difficult path to confirmation due to concerns over vaccine stances. What are the practical steps to overcoming this legislative resistance, and why is an establishment candidate considered a poor fit?
We are currently witnessing a significant battle in the Senate because Casey Means represents a fundamental shift away from the status quo, which naturally scares those comfortable with the current system. The practical path to her confirmation involves a relentless focus on her vision for metabolic health and nutrition, which are topics that resonate across party lines even if her vaccine views cause friction. An establishment candidate, like Erica Schwartz, might be a safer pick for the CDC, but the Surgeon General needs to be a disruptor who isn’t afraid to question failing paradigms. We are leaning into this resistance because it proves that the movement is actually threatening the institutional inertia that has allowed chronic illness to skyrocket.
Prominent health figures are scheduled to tour battleground states to promote a nutrition-heavy political agenda. How does this strategy bridge the gap between niche health advocacy and broad political support?
The upcoming tour of battleground states, led by figures like Robert F. Kennedy Jr., is designed to take these high-level policy debates and put them right on the kitchen tables of everyday Americans. We are seeing a massive mobilization of the base when we talk about tangible issues like the quality of school lunches and the skyrocketing prices of essential medications. By focusing on the “MAHA” agenda—specifically nutrition and drug pricing—we are turning what used to be niche wellness topics into a powerful populist platform. This isn’t just about health; it’s about a broader sense of autonomy and the feeling that the government should finally prioritize the physical well-being of its citizens over corporate profits.
Significant shifts in national vaccine policies are underway despite pushback from traditional health organizations. What are the long-term trade-offs of moving away from the status quo, and how will the administration ensure public trust?
We are not apologizing for the shifts in vaccine policy because we believe the long-term benefit of restoring transparency far outweighs the temporary discomfort felt by the health establishment. The trade-off we are making is a move toward a system where informed consent and independent data are prioritized over institutional mandates that many Americans no longer trust. To rebuild that trust, the administration is taking a step-by-step approach that involves open dialogue with skeptics and a refusal to ignore the “ups and downs” of past policies. By being honest about the complexities of these issues, we are laying the groundwork for a more resilient and health-conscious public that feels empowered rather than coerced.
What is your forecast for the MAHA-MAGA coalition?
My forecast for the MAHA-MAGA coalition is one of increasing integration, where the $100 million war chest and the grassroots energy from health influencers will fundamentally redefine the Republican identity heading into 2026. While we will continue to see tactical disagreements over specific executive orders or personnel, the shared goal of dismantling the administrative state’s grip on public health is a powerful unifying force. Over the next few years, this alliance will likely move from a marriage of convenience to a permanent political fixture, making nutrition and chronic disease prevention the central battlefield of American politics. We are moving toward a future where “health is wealth” isn’t just a slogan, but a core legislative mandate.
